Greenville, N.C.
Mayne Pharma is planning to construct a $65 million pharmaceutical production facility at its existing site in Greenville, N.C. The commercial-scale, oral-dose manufacturing center is expected to be fully operational in 2018. Designed to meet international regulatory standards, the 126,000-sf project will enable Mayne to expand its contract service offerings, which include development, manufacturing, and packaging operations for generic and specialty drug products.
Source
